These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26388613)

  • 21. Assessment of insulin like growth factor-1 and IGF binding protein-3 in healthy Indian girls from Delhi and their correlation with age, pubertal status, obesity and thyroid hormonal status.
    Marwaha RK; Garg MK; Gupta S; Khurana AK; Narang A; Shukla M; Arora P; Chadha A; Nayak DD; Manchanda RK
    J Pediatr Endocrinol Metab; 2017 Jul; 30(7):739-747. PubMed ID: 28672739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
    Chokkalingam AP; Pollak M; Fillmore CM; Gao YT; Stanczyk FZ; Deng J; Sesterhenn IA; Mostofi FK; Fears TR; Madigan MP; Ziegler RG; Fraumeni JF; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort.
    DeLellis K; Rinaldi S; Kaaks RJ; Kolonel LN; Henderson B; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1444-51. PubMed ID: 15342444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.
    Wei EK; Ma J; Pollak MN; Rifai N; Fuchs CS; Hankinson SE; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):850-5. PubMed ID: 15824155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factor-I and binding protein-3 and risk of cancer.
    Giovannucci E
    Horm Res; 1999; 51 Suppl 3():34-41. PubMed ID: 10592442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC-Potsdam Study.
    Drogan D; Schulze MB; Boeing H; Pischon T
    Am J Epidemiol; 2016 Mar; 183(6):553-60. PubMed ID: 26880678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a meta-analysis of literature.
    Sugumar A; Liu YC; Xia Q; Koh YS; Matsuo K
    Int J Cancer; 2004 Aug; 111(2):293-7. PubMed ID: 15197785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts.
    Wolpin BM; Michaud DS; Giovannucci EL; Schernhammer ES; Stampfer MJ; Manson JE; Cochrane BB; Rohan TE; Ma J; Pollak MN; Fuchs CS
    Br J Cancer; 2007 Jul; 97(1):98-104. PubMed ID: 17533398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increase in circulating levels of IGF-1 and IGF-1/IGFBP-3 molar ratio over a decade is associated with colorectal adenomatous polyps.
    Soubry A; Il'yasova D; Sedjo R; Wang F; Byers T; Rosen C; Yashin A; Ukraintseva S; Haffner S; D'Agostino R
    Int J Cancer; 2012 Jul; 131(2):512-7. PubMed ID: 21898383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer].
    Jiang B; Liu DB; Zhang X; DU LL; Han CZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):264-8. PubMed ID: 19434535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer.
    Renehan AG; Jones J; Potten CS; Shalet SM; O'Dwyer ST
    Br J Cancer; 2000 Nov; 83(10):1344-50. PubMed ID: 11044360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: A nested case-control study in large scale cohort study in Japan.
    Mikami K; Ozasa K; Nakao M; Miki T; Hayashi K; Watanabe Y; Mori M; Sakauchi F; Washio M; Kubo T; Suzuki K; Wakai K; Nakachi K; Tajima K; Ito Y; Inaba Y; Tamakoshi A;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():57-61. PubMed ID: 20553083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-Like Growth Factor-I, Insulin-Like Growth factor Binding Protein-3 and Blood Hemoglobin Concentration in an Elderly Population.
    Duron E; Vidal JS; Funalot B; Brunel N; Viollet C; Rigaud AS; Labourée F; Epelbaum J; le Bouc Y; Hanon O
    J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):854-9. PubMed ID: 25384548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating insulin-like growth factor 1 and insulin-like growth factor binding protein-3 level in Alzheimer's disease: a meta-analysis.
    Hu X; Yang Y; Gong D
    Neurol Sci; 2016 Oct; 37(10):1671-7. PubMed ID: 27379655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
    Rinaldi S; Kaaks R; Zeleniuch-Jacquotte A; Arslan AA; Shore RE; Koenig KL; Dossus L; Riboli E; Stattin P; Lukanova A; Toniolo P
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):48-52. PubMed ID: 15668475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. People with low serum folate levels have higher risk of colorectal adenoma/advanced colorectal adenoma occurrence and recurrence in China.
    Ding H; Gao QY; Chen HM; Fang JY
    J Int Med Res; 2016 Aug; 44(4):767-78. PubMed ID: 27358263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent.
    Malpe R; Baylink DJ; Linkhart TA; Wergedal JE; Mohan S
    J Bone Miner Res; 1997 Mar; 12(3):423-30. PubMed ID: 9076585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma insulin-like growth factor I is inversely associated with colorectal adenoma recurrence: a novel hypothesis.
    Jacobs ET; Martínez ME; Alberts DS; Ashbeck EL; Gapstur SM; Lance P; Thompson PA
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):300-5. PubMed ID: 18250342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.